In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – From 1985 to 2007, the initial CD4+ cell counts seen at diagnosis in HIV-infected patients in the US have fallen, suggesting that the…
NEW YORK (Reuters Health) – In patients with newly diagnosed type 1 diabetes, high-dose immune ablation followed by autologous nonmyeloablative hematopoietic stem cell transplantation (HSCT) induces significant and…
NEW YORK (Reuters Health) – In children exposed in utero to methamphetamine, MRI findings suggest alterations in white matter maturation, according to a report in the April 15th…
NEW YORK (Reuters Health) – New research suggests that marijuana use may increase the risk of testicular germ cell tumors (TGCTs), primarily nonseminoma types. According to the report…
NEW YORK (Reuters Health) – After the development of coronary artery disease (CAD), a subsequent diagnosis of depression is associated with an increased incidence of heart failure, even…
NEW YORK (Reuters Health) – Despite the fact that up to one third of patients with severe dementia receive enteral tube feeding, evidence is lacking that this practice…
NEW YORK (Reuters Health) – Assessing kidney function with both the estimated glomerular filtration rate (eGFR) and with urinary albumin levels can help predict whether chronic kidney disease…
NEW YORK (Reuters Health) – Desvenlafaxine, a serotonin-norepinephrine reuptake inhibitor, is a safe and effective treatment for hot flushes in postmenopausal women, according to a report in the…
NEW YORK (Reuters Health) – Bezafibrate, a pan-PPAR agonist used widely for treating dyslipidemia in the UK, appears to prevent or delay the development of type 2 diabetes,…
NEW YORK (Reuters Health) – Roughly one in five deaths after lumbar fusion surgery is related to analgesic use, according to a report in the April 1st issue…
